Preoperative Antihypertensive Use and Risk of Post- Spinal Hypotension in Elderly Patients Undergoing Hip Fracture Surgery: A Retrospective Secondary Analysis
DOI:
https://doi.org/10.33192/smj.v78i4.279908Keywords:
Antihypertensive agents, elderly, hip fractures, spinal anesthesia, intraoperative hypotension, surgical proceduresAbstract
Objective: To examine the association between preoperative antihypertensive medication use and the risk of postspinal hypotension in patients aged ≥80 years undergoing hip fracture surgery.
Materials and Methods: This retrospective cohort study was a secondary analysis of patients aged ≥80 years who underwent hip fracture surgery under spinal anesthesia at a tertiary-care hospital between October 2016 and September 2023. Patients were categorized according to whether antihypertensive medications were taken on the day of surgery. The primary outcome was post-spinal hypotension. Univariable and multivariable risk ratio regression analyses were performed.
Results: Overall, 63% of patients developed post-spinal hypotension. Preoperative antihypertensive use was not significantly associated with hypotension in the multivariable analysis. However, use of renin–angiotensin–aldosterone system (RAAS) antagonists was independently associated with an increased risk (RR 1.38; 95% CI 1.13–1.68; p = 0.002). A significant dose–response relationship was observed between the number of antihypertensive agents and the incidence of hypotension (p for trend = 0.036). Patients receiving ≥3 antihypertensive agents had the highest adjusted risk ratio, although this was not statistically significant.
Conclusion: Preoperative antihypertensive use was not associated with an increased risk of post-spinal hypotension in patients aged 80 years and older with hip fractures. However, RAAS antagonists and multiple-antihypertensive regimens may increase susceptibility to hemodynamic instability. Careful preoperative assessment of antihypertensive therapy is recommended.
References
Helwani MA, Avidan MS, Ben Abdallah A, Kaiser DJ, Clohisy JC, Hall BL, et al. Effects of regional versus general anesthesia on outcomes after total hip arthroplasty: a retrospective propensity-matched cohort study. J Bone Joint Surg Am. 2015;97(3):186–93.
Han F, Yang Y, Tian X. Impact of regional anesthesia vs general anesthesia on postoperative outcomes in elderly patients with hip fracture: a meta-analysis. Investig Clin. 2025;66(2):217–30.
Hartmann B, Junger A, Klasen J, Benson M, Jost A, Banzhaf A, et al. The incidence and risk factors for hypotension after spinal anesthesia induction: an analysis with automated data collection. Anesth Analg. 2002;94(6):1521–9.
Chinachoti T, Saetia S, Chaisiri P, Tritrakarn T. Incidence and risk factors of hypotension and bradycardia during spinal anesthesia. Siriraj Med J. 2006;58(3):696-701.
Malima ZA, Torborg A, Cronjé L, Biccard BM. Predictors of post-spinal hypotension in elderly patients: a prospective observational study in the Durban Metropole. South Afr J Anaesth Analg. 2019;25(5):13–7.
Dominguez JE, Halaszynski TM. Perioperative regional anesthesia in the elderly. In: Hadzic A, editor. Hadzic’s textbook of regional anesthesia and acute pain management. 2nd ed. New York: McGraw-Hill Education; 2017.p.865-80.
Akarapatima R. The risk factors for spinal anesthesia-induced hypotension in patients undergoing hip fracture surgery among the elderly: a retrospective cohort study. Thai J Anesthesiol. 2021;47(2):85–92.
Jitsinthunun T, Supannanont P, Raksakietisak M. Incidence, Risk-factors, and Outcomes of Intraoperative Hypotension Following Spinal Anesthesia in Hip Fracture Surgery: A Retrospective Study from Thailand. Siriraj Med J. 2024;76(7):395-405.
S AK, Oommen TG, Thomas CW, Jose DE, VS AV, R GS, et al. An observational study to compare spinal anesthesia-induced hemodynamic changes in normotensive and hypertensive patients on antihypertensive medications. Eur J Cardiovasc Med. 2024;14:1096–102.
Dohare S, Vatsalya T, Mehrotra S. An observational study to compare spinal anesthesia-induced hemodynamic changes in normotensive and hypertensive patients on antihypertensive medications. Asian J Pharm Clin Res. 2024;17(2):26–30.
Kaimar P, Sanji N, Upadya M, Mohammed KR. A comparison of hypotension and bradycardia following spinal anesthesia in patients on calcium channel blockers and β-blockers. Indian J Pharmacol. 2012;44(2):193–6.
Calloway JJ, Memtsoudis SG, Krauser DG, Ma Y, Russell LA, Goodman SM. Hemodynamic effects of angiotensin inhibitors in elderly hypertensives undergoing total knee arthroplasty under regional anesthesia. J Am Soc Hypertens. 2014;8(9):644–51.
Höhne C, Meier L, Boemke W, Kaczmarczyk G. ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia. Acta Anaesthesiol Scand. 2003;47(7):891–6.
Thompson A, Fleischmann KE, Smilowitz NR, de las Fuentes L, Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;150(19):e351–442.
Parasuram T, Nadagoudar H. Comparison of effect of spinal anesthesia on heart rate and blood pressure between hypertensive patients on β-blockers or calcium channel blockers and normotensive patients: a prospective observational cohort study. Int J Med Anesthesiol. 2021;4(2):7–11.
Prasad AP, Prakash G, Dubey S, Kamendu A, Kumar H. To compare the haemodynamic parameters in patients on calcium channel blockers and beta blockers undergoing subarachnoid block. Int J Pharm Sci Rev Res. 2022;75(2):174–9.
OpenAnesthesia. Alpha blockers [Internet]. [cited 2025 Sep 14]. Available from: https://www.openanesthesia.org/keywords/alpha-blockers/
Flack JM, Buhnerkempe MG, Moore KT. Resistant hypertension: disease burden and emerging treatment options. Curr Hypertens Rep. 2024;26(5):183–99.
Colle SD, Morello F, Rabbia F, Milan A, Naso D, Puglisi E, et al. Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol. 2007;50(5):487–93.
Published
How to Cite
License
Copyright (c) 2026 Siriraj Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.
